Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Prepandrix in Korean Adults
NCT01730378Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of H5N1 pre-pandemic influenza vaccine in influenza A virus H5N1 subtype infection (H5N1), sponsored by GSK. Started Dec 2012; status: completed.
02
Drugs
H5N1 pre-pandemic influenza vaccine
03
Conditions
influenza A virus H5N1 subtype infection (H5N1)
Beyond the preview
Go deeper on NCT01730378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730378.